Abingdon will use the money to buy 50.1% of Molecular Vision, another Imperial Innovations portfolio company, as well as for other projects, including those from its Bioscience Ventures joint venture with the University of Birmingham.
Imperial Innovations Group, a UK-listed university venturing firm spun out from Imperial College, London, has invested two-thirds of a £3m ($4.7m) round for Abingdon Health, a local medical diagnostics company, to help it buy a peer.
Abingdon will buy 50.1% of Molecular Vision, another Imperial Innovations portfolio company, as well as use the money for other projects, including those from its Bioscience Ventures joint venture with the University of Birmingham.
A spinout of Imperial College in 2001, Molecular Vision…
